Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ReAble Makes $1.6 Billion Move To Acquire Ortho Rehab Firm DJO

This article was originally published in The Gray Sheet

Executive Summary

ReAble Therapeutics agreed July 16 to buy DJO for about $1.6 billion in a deal that will give the privately held firm a substantial stake in the bracing and soft goods orthopedic market and complement its current strength in electrotherapy pain management

You may also be interested in...



‘New’ DJO Will Focus On Realizing Cost-Savings And Synergies In 2008

Rehabilitation and orthopedic device firm DJO, formerly ReAble Therapeutics, stressed cost savings and synergies March 24 in its first report of financial results following the completion of a major acquisition late last year

‘New’ DJO Will Focus On Realizing Cost-Savings And Synergies In 2008

Rehabilitation and orthopedic device firm DJO, formerly ReAble Therapeutics, stressed cost savings and synergies March 24 in its first report of financial results following the completion of a major acquisition late last year

Beckman Coulter Stock Gain Aided By Merger Activity In Diagnostics – Index

Clinical diagnostics firm Beckman Coulter's stock is benefiting from recent merger activity among its rivals in the field and speculation that it too could become an acquisition target; shares advanced 14% in the third quarter to close at $73.76

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel